Jack C. Stromatt

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “BMX kinase mediates gilteritinib resistance inFLT3-mutated AML through microenvironmental factors”.

BMX kinase mediates gilteritinib resistance inFLT3-mutated AML through microenvironmental factors

Blood Advances(2022)10.1182/bloodadvances.2022007952

N/A

0.675DataRank · unranked

16 citations

Bhavana Bhatnagar, Shelley Orwick, Jae Yoon Jeon, Eric D. Eisenmann, Jack C. Stromatt +5 more

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

Cancers(2022)10.3390/cancers15010029

N/A

0DataRank · unranked

10 citations

Jack C. Stromatt, Sydney Fobare, Kevin M. Huang, Daelynn R. Buelow, Shelley Orwick +8 more

Drug–Drug Interaction Liabilities with BTK Inhibitor TL-895

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0265

N/A

0DataRank · unranked

1 citations

Eman Ahmed, Thomas Drabison, Mahesh R. Nepal, Anika T. Chowdhury, Shelley Orwick +6 more

Drug–drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors

Expert Review of Clinical Pharmacology(2025)10.1080/17512433.2025.2606258

N/A

0DataRank · unranked

0 citations

Anika T. Chowdhury, Kevin M. Huang, Shuiying Hu, Alex Sparreboom, Sharyn D. Baker +2 more